AstraZeneca PLC (AZN): Eigentümerstruktur
Der letzte verfügbare Schlusskurs ist 28.07.2026. Die angezeigten Informationen beziehen sich auf den historischen Stand und sind nicht tagesaktuell.
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 213,99 US Dollar | 7 | 2 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 1.550.876.987 | 0,16 | 1 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name AstraZeneca PLC
Mitarbeiter 96.100
Handelsplatz NYSE
Ticker Symbol AZN
IPO Datum 1993-05-17
Adresse 1 Francis Crick Avenue, Cambridge, United Kingdom, CB2 0AA
Webseite https://www.astrazeneca.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Pascal Claude Roland Soriot D.V.M., M.B.A. | CEO & Executive Director |
| 2 | Dr. Aradhana Sarin M.D. | CFO & Executive Director |
| 3 | Ms. Pam P. Cheng | EVP of Global opt. & IT, Chief Sust. Officer and Member of External Sust.Adv. Board |
| 4 | Mr. Joris Silon | Head of Investor Relations |
| 5 | Mr. Jeffrey Pott J.D. | CHRO, Chief Compliance Officer, General Counsel & Member of External Sustainability Advisory Board |
| 6 | Dr. Ruud Dobber Ph.D. | Executive Vice-President of BioPharmaceuticals Business Unit |
| 7 | Dr. Susan Mary Galbraith M.D., Ph.D. | Executive Vice President of Oncology R&D |
| 8 | Ms. Iskra Reic | Executive Vice President of International |
| 9 | Mr. David Fredrickson | Executive Vice-President of Oncology Haematology Business Unit |
| 10 | Ms. Ruth March FMEDSCI, O.B.E., Ph.D. | Senior VP of Precision Medicine - R&D Oncology |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Investors Finance Co PLC | 3,33% | 8,73 Mrd. USD |
| 2 | Vanguard Capital Management, LLC | 2,90% | 7,62 Mrd. USD |
| 3 | Capital Research & Mgmt Co - Division 3 | 2,22% | 5,82 Mrd. USD |
| 4 | FMR Inc | 1,91% | 5,01 Mrd. USD |
| 5 | Capital World Investors | 1,82% | 4,78 Mrd. USD |
| 6 | Legal & General Group PLC | 1,67% | 4,38 Mrd. USD |
| 7 | Wellington Management Company LLP | 1,53% | 4,02 Mrd. USD |
| 8 | T. Rowe Price Associates, Inc. | 1,26% | 3,30 Mrd. USD |
| 9 | Bank of America Corp | 1,23% | 3,23 Mrd. USD |
| 10 | JPMorgan Chase & Co | 1,20% | 3,15 Mrd. USD |
| 11 | VANGUARD ASSET MANAGEMENT Ltd | 1,20% | 3,14 Mrd. USD |
| 12 | PRIMECAP Management Company | 1,17% | 3,08 Mrd. USD |
| 13 | Franklin Resources Inc | 1,15% | 3,01 Mrd. USD |
| 14 | Amundi | 0,99% | 2,60 Mrd. USD |
| 15 | Vanguard Fiduciary Trust Co | 0,85% | 2,23 Mrd. USD |
| 16 | DZ BANK AG Deutsche Zentral-Genossenschaftsbank Frankfurt am Main | 0,83% | 2,19 Mrd. USD |
| 17 | Deutsche Bank AG | 0,78% | 2,05 Mrd. USD |
| 18 | HHG PLC | 0,77% | 2,02 Mrd. USD |
| 19 | Aviva PLC | 0,71% | 1,88 Mrd. USD |
| 20 | Fisher Asset Management, LLC | 0,70% | 1,84 Mrd. USD |